Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes:: An update

被引:104
作者
Epstein, Judith E.
Rao, Suchitra
Williams, Frank
Freilich, Daniel
Luke, Thomas
Sedegah, Martha
de la Vega, Patricia
Sacci, John
Richie, Thomas L.
Hoffman, Stephen L.
机构
[1] USN, Med Res Ctr, Malaria Program, Silver Spring, MD 20910 USA
[2] Sanaria Inc, Rockville, MD USA
关键词
D O I
10.1086/518510
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Challenge of volunteers by the bites of membrane-fed anopheline mosquitoes infected with Plasmodium falciparum was reported in 1986. In 1997, an analysis of experience with 118 volunteers indicated that mosquito inoculation of P. falciparum could be a safe, well-tolerated, reproducible, and efficient method of challenge. Methods. We reviewed the records of 47 volunteers challenged at our institution with the NF54 isolate of P. falciparum between 1998 and 2002. We also reviewed data from 17 published studies of experimental challenge conducted since 1996. Results. At our institution, the time to onset of first symptoms ( incubation period) was 8.9 days, and the time to first detectable parasitemia on blood smear ( prepatent period) was 10.5 days. All volunteers became symptomatic. Most symptoms were mild to moderate, although 21% of volunteers had at least 1 severe symptom. None developed complicated or severe malaria, and all were cured. Laboratory assessments demonstrated modest, short-term abnormalities typical of malaria. Review of 17 published studies demonstrated that an additional 367 volunteers received experimental challenge safely with similar outcomes. Conclusions. In total, data from 532 volunteers demonstrate that experimental challenge is safe and results in predictable incubation and prepatent periods. Our findings support the continued use of this method for testing efficacy of vaccines and drugs against P. falciparum.
引用
收藏
页码:145 / 154
页数:10
相关论文
共 40 条
[1]   Introduction and summary - The intolerable burden of malaria: A new look at the numbers [J].
Breman, JG ;
Egan, A ;
Keusch, GT .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 64 (1-2) :IV-VII
[2]   MALARIA TRANSMITTED TO HUMANS BY MOSQUITOS INFECTED FROM CULTURED PLASMODIUM-FALCIPARUM [J].
CHULAY, JD ;
SCHNEIDER, I ;
COSGRIFF, TM ;
HOFFMAN, SL ;
BALLOU, WR ;
QUAKYI, IA ;
CARTER, R ;
TROSPER, JH ;
HOCKMEYER, WT .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1986, 35 (01) :66-68
[3]   Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge [J].
Church, LWP ;
Le, TP ;
Bryan, JP ;
Gordon, DM ;
Edelman, R ;
Fries, L ;
Davis, JR ;
Herrington, DA ;
Clyde, DF ;
Shmuklarsky, MJ ;
Schneider, I ;
McGovern, TW ;
Chulay, JD ;
Ballou, WR ;
Hoffman, SL .
JOURNAL OF INFECTIOUS DISEASES, 1997, 175 (04) :915-920
[4]   IMMUNIZATION OF MAN AGAINST SPOROZITE-INDUCED FALCIPARUM MALARIA [J].
CLYDE, DF ;
MOST, H ;
MCCARTHY, VC ;
VANDERBERG, JP .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1973, 266 (03) :169-177
[5]   IMMUNIZATION OF MAN AGAINST FALCIPARUM AND VIVAX MALARIA BY USE OF ATTENUATED SPOROZOITES [J].
CLYDE, DF ;
MCCARTHY, VC ;
MILLER, RM ;
WOODWARD, WE .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1975, 24 (03) :397-401
[6]   CLINICAL, CHEMOTHERAPEUTIC AND IMMUNOLOGICAL STUDIES ON INDUCED MALARIA [J].
COVELL, G ;
NICOL, WD .
BRITISH MEDICAL BULLETIN, 1951, 8 (01) :51-55
[7]   A DNA prime-modified vaccinia virus Ankara boost vaccine encoding thrombospondin-related adhesion protein but not circumsporozoite protein partially protects healthy malaria-naive adults against Plasmodium falciparum sporozoite challenge [J].
Dunachie, S. J. ;
Walther, M. ;
Epstein, J. E. ;
Keating, S. . ;
Berthoud, T. ;
Andrews, L. ;
Andersen, R. F. ;
Bejon, P. ;
Goonetilleke, N. ;
Poulton, I. ;
Webster, D. P. ;
Butcher, G. ;
Watkins, K. ;
Sinden, R. E. ;
Levine, G. L. ;
Richie, T. L. ;
Schneider, J. ;
Kaslow, D. ;
Gilbert, S. C. ;
Carucci, D. J. ;
Hill, A. V. S. .
INFECTION AND IMMUNITY, 2006, 74 (10) :5933-5942
[8]   A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS [J].
Dunachie, SJ ;
Walther, M ;
Vuola, JM ;
Webster, DP ;
Keating, SM ;
Berthoud, T ;
Andrews, L ;
Bejon, P ;
Poulton, I ;
Butcher, G ;
Watkins, K ;
Sinden, RE ;
Leach, A ;
Moris, P ;
Tornieporth, N ;
Schneider, J ;
Dubovsky, F ;
Tierney, E ;
Williams, J ;
Heppner, DG ;
Gilbert, SC ;
Cohen, J ;
Hill, AVS .
VACCINE, 2006, 24 (15) :2850-2859
[9]  
Ghoda M K, 2002, Trop Gastroenterol, V23, P70
[10]  
HALL WS, 1955, REC COLUMBIA MED SOC, V19, P23